{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:15:08Z","timestamp":1760645708658},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/bf03161195","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T08:20:52Z","timestamp":1251447652000},"page":"167-169","source":"Crossref","is-referenced-by-count":29,"title":["Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])"],"prefix":"10.1007","volume":"4","author":[{"given":"Satnam","family":"Lidder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul I.","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Button","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03161195_CR1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(07)60674-6","volume":"369","author":"DM Wood","year":"2007","unstructured":"Wood DM, Dargan PI, Button J, Holt DW, Ovaska H, Ramsey J, et al. Collapse, reported seizure\u2014and an unexpected pill.Lancet 2007; 369: 1490.","journal-title":"Lancet"},{"key":"BF03161195_CR2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-007-0451-9","volume":"64","author":"PI Dargan","year":"2008","unstructured":"Dargan PI, Button J, Hawkins L, Archer J, Ovaska H, Lidder S, et al. Detection of the pharmaceutical agent \u2018Glaucine\u2019 as a recreational drug.Eur J Clin Pharmacol 2008; 64: 553\u2013554.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF03161195_CR3","first-page":"647","volume":"45","author":"H Ovaska","year":"2007","unstructured":"Ovaska H, Wood DM, Viljoen A, Button J, Puchnarewicz M, Greene SL, et al. 4-chloro-2,5-dimethoxy amphetamine (DOC): A rarely reported rave scene drug of abuse.Clin Toxicol 2007; 45: 647.","journal-title":"Clin Toxicol"},{"key":"BF03161195_CR4","first-page":"107","volume":"67","author":"VI Rovinskia","year":"1989","unstructured":"Rovinskia VI. A case of hallucinogen-like action of glaucine.Klin Med (Mosk) 1989; 67: 107\u2013108.","journal-title":"Klin Med (Mosk)"},{"key":"BF03161195_CR5","first-page":"68","volume":"84","author":"VI Rovinskia","year":"2006","unstructured":"Rovinskia VI. Acute glaucine syndrome in the physician\u2019s practice: the clinical picture and potential danger.Klin Med (Mosk) 2006; 84: 68\u201370.","journal-title":"Klin Med (Mosk)"},{"key":"BF03161195_CR6","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmc.2005.03.022","volume":"13","author":"M Asencio","year":"2005","unstructured":"Asencio M, Hurtado-Guzm\u00e1n C, L\u00f3pez JJ, Cassels BK, Protais P, Chagraoui A. Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity.Bioorg Med Chem 2005; 13: 3699\u20133704.","journal-title":"Bioorg Med Chem"},{"key":"BF03161195_CR7","doi-asserted-by":"crossref","unstructured":"Rhodium site archive hosted on The Vaults of Erowid [webpage on the Internet]. Synthesis of diphenyl-2-pyrrolidinyl-methanol and diphenyl-2-pyrrolidinyl-methane [updated 2005 May 31; cited 2008 Feb 19] Available from: http:\/\/www.erowid. org\/archive\/rhodium\/chemistry\/pyrrolidinyl.html","DOI":"10.1002\/9780471264194.fos04755"},{"key":"BF03161195_CR8","unstructured":"Wikipedia\u2014The Free Encyclopedia [webpage on the Internet]. Pipradrol [updated 2008 Feb 11; cited 2008 Feb 19]. Available from: http:\/\/en.wikipedia.org\/wiki\/Pipradrol"},{"key":"BF03161195_CR9","first-page":"2336","volume":"55","author":"EP Gelvin","year":"1955","unstructured":"Gelvin EP, McGavack TH, Kenigsberg S. Alpha-(2-piperidyl) benzhydrol hydrochloride (pipradrol) as an adjunct in the dietary management of obesity.NY State J Med 1955; 55: 2336\u20132338.","journal-title":"NY State J Med"},{"key":"BF03161195_CR10","unstructured":"Pyrrolidine derivatives US patent application [webpage on the Internet]. Patent application by Jackson PF and Guildford Pharmaceuticals; Patent number 5,650,521 [updated 1997 July 22; cited 2008 Feb 19]. Available from: http:\/\/v3.espacenet.com\/ origdoc?CY=gb&LG=en&DB=EPODOC&IDX=US5650521&DOC=dcb65d04ab6724e097530cc48c44ebbb62"},{"key":"BF03161195_CR11","unstructured":"Drugs-Forum research chemicals discussion forum [webpage on the Internet]. Diphenyl-2-Pyrrolidinyl-Methanol (diphenylprolinol) trip reports [updated 2007 Apr 1; cited 2008 Feb 19]. Available from: http:\/\/www.drugs-forum.co.uk\/forum\/ showthread.php?t=41534"},{"key":"BF03161195_CR12","unstructured":"Gower P [webpage on the Internet]. Herald investigation: Party pill pushers beat the ban [updated 2007 Nov 3; cited 2008 Feb 19]. Available from: http:\/\/www.nzherald.co.nz\/category\/ story.cfm?c_id=30&objectid=10473827"},{"key":"BF03161195_CR13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(07)60646-1","volume":"369","author":"RF Staack","year":"2007","unstructured":"Staack RF. Piperazine designer drugs of abuse.Lancet 2007; 369: 1411\u20131413.","journal-title":"Lancet"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03161195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03161195\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03161195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T03:46:42Z","timestamp":1558496802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03161195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["BF03161195"],"URL":"https:\/\/doi.org\/10.1007\/bf03161195","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}